← Back to Search

Medical-Legal Partnerships for HIV Care Continuity

Phase 1
Recruiting
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial tests the effectiveness of an innovative HIV program (Organizational Partnerships for Healthy Living) that includes training, case management, legal services, and communication protocols. It'll also explore HIV/AIDS & COVID-19 prevention & treatment.

Who is the study for?
This trial is for adults living with HIV who have a viral load over 200 copies/mL. Participants must be willing to consent to the study and not plan on moving within six months after joining. It's designed for those receiving care at health organizations involved in the trial.Check my eligibility
What is being tested?
The study tests an intervention called OPAHL, aiming to improve HIV care through training healthcare staff, integrating legal expertise into case management, co-locating legal services in healthcare agencies, and enhancing communication protocols among providers.See study design
What are the potential side effects?
Since this trial focuses on organizational interventions rather than medical treatments, it does not involve medication side effects. However, participants may experience changes in service delivery or access that could affect their satisfaction or continuity of care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Viral Suppression
Secondary outcome measures
Engagement in HIV Care
Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Medical Legal PartnershipsExperimental Treatment1 Intervention
Component 1 is a comprehensive training for all MLP care providers delivered to clinical, social and behavioral, and legal staff together to establish a collaborative environment. Component 2 consists of the screening tool and screening protocol that is designed to identify health-harming legal needs of PLWH patients. Component 3 includes the provision of legal support through partnership with the Legal Clinic for the Disabled. Upon a positive legal needs screening, the case manager connects the patient to this attorney, at which point the patient, after signing a letter of engagement, becomes a client and can now address the identified legal issue(s) with legal representation.
Group II: Standard of CareActive Control1 Intervention
Comparison arm health organization will only receive the HIV standard of care (U.S. CDC HIV standard of care) and referral to legal aid.

Find a Location

Who is running the clinical trial?

Temple UniversityLead Sponsor
297 Previous Clinical Trials
82,773 Total Patients Enrolled

Media Library

Medical Legal Partnerships Clinical Trial Eligibility Overview. Trial Name: NCT05912842 — Phase 1
Standard of Care Research Study Groups: Standard of Care, Medical Legal Partnerships
Standard of Care Clinical Trial 2023: Medical Legal Partnerships Highlights & Side Effects. Trial Name: NCT05912842 — Phase 1
Medical Legal Partnerships 2023 Treatment Timeline for Medical Study. Trial Name: NCT05912842 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the FDA endorse Medical Legal Partnerships?

"With limited data to inform safety and efficacy, the Medical Legal Partnerships were assigned a score of 1 on our rating scale."

Answered by AI

Are there specific requirements for eligibility in this research study?

"Entrants into this research trial must possess affiliations with organizations devoted to health and wellness, as well as be between 18-100 years old. A maximum of 200 participants are being accepted by the study's administrators."

Answered by AI

How many participants is the research team observing?

"Affirmative. According to the information posted on clinicaltrials.gov, this medical research program is currently seeking participants. It was first launched on October 1st 2022 and recently updated June 21st 2023. 200 individuals will be recruited from a single facility for this trial."

Answered by AI

Are new participants being welcomed into this research endeavor?

"Affirmative, as per the information featured on clinicaltrials.gov this trial is still recruiting participants. The first posting was made on October 1st 2022 and it has been recently updated on June 21st 2023; 200 individuals are required to be enrolled from a single site."

Answered by AI

Is the age range for participants in this trial inclusive of senior citizens?

"The conditions for inclusion in this medical trial necessitate that participants be between 18 and one hundred years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Forging Sustainable Solutions for HIV Continuity of Care Through Medical-legal Partnerships
2022. "Forging Sustainable Solutions for HIV Continuity of Care Through Medical-legal Partnerships". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05912842.
~10 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top